Literature DB >> 15103198

Medical treatment of stage I nasal polyposis over a 3-year follow-up period.

Pierre Bonfils1, Jean-Marc Norès, Philippe Halimi, Paul Avan.   

Abstract

PURPOSE: To determine the effects of a standardized therapeutic protocol (short-term oral administration of prednisolone and daily intranasal spray of beclometasone) on stage I nasal polyposis over a follow-up period of 3 years. PROCEDURES: Assessments (evaluation of nasal function and drug consumption) were conducted at baseline and every 3 months on 54 consecutive patients with stage I nasal polyposis during 3 years.
RESULTS: Over the follow-up period of 3 years, this dual modality proved to be successful in 87% of the subjects; only 13% had to undergo surgery after its failure. The average symptom reduction reached an improvement rate varying from 66 to 94.8%, according to the symptom type. The daily dosage of prednisolone and beclometasone was progressively decreased, while the gain in nasal comfort was being preserved.
CONCLUSION: Management of stage I nasal polyps should be primarily medical. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103198     DOI: 10.1159/000077230

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  2 in total

Review 1.  Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.

Authors:  Karen Head; Lee Yee Chong; Claire Hopkins; Carl Philpott; Anne G M Schilder; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26

Review 2.  Short-course oral steroids alone for chronic rhinosinusitis.

Authors:  Karen Head; Lee Yee Chong; Claire Hopkins; Carl Philpott; Martin J Burton; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.